Get startedLog in
    Picture of AstraZeneca logo

    AZN — AstraZeneca News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    All News

    Brief: AstraZeneca's Efzimfotase alfa Granted Priority Review In U.S.

    Picture of AstraZeneca logoAstraZeneca
    18/09/2026 07:20
    BRIEF-AstraZeneca's Efzimfotase alfa Granted Priority Review In U.S. 
    Sept 18 (Reuters) - AstraZeneca PLC AZN.L:
    • ASTRAZENECA: EFZIMFOTASE ALFA GRANTED PRIORITY REVIEW IN US AS TREATMENT FOR PATIENTS WITH HYPOPHOSPHATASIA AGED 2 YEARS AND OLDER
    • ASTRAZENECA - FDA DECISION ON EFZIMFOTASE ALFA EXPECTED IN FIRST HALF OF 2027
    Source text: [ID:]
    Further company coverage: AZN.L

     ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on AstraZeneca

    See all news